FBTCX vs. BITX

In the year-to-date period, FBTCX achieves a -4.56% return, which is significantly lower than BITX's 4.85% return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

FBTCX has a 1.75% expense ratio, which is lower than BITX's 1.85% expense ratio.

This table presents a comparison of risk-adjusted performance metrics for Fidelity Advisor Biotechnology Fund Class C (FBTCX) and Volatility Shares 2x Bitcoin Strategy ETF (BITX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current FBTCX Sharpe Ratio is -0.37, which is lower than the BITX Sharpe Ratio of 1.18. The chart below compares the historical Sharpe Ratios of FBTCX and BITX, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

FBTCX's dividend yield for the trailing twelve months is around 3.00%, less than BITX's 10.21% yield.

The maximum FBTCX drawdown since its inception was -61.27%, roughly equal to the maximum BITX drawdown of -61.28%. Use the drawdown chart below to compare losses from any high point for FBTCX and BITX. For additional features, visit the drawdowns tool.

The current volatility for Fidelity Advisor Biotechnology Fund Class C (FBTCX) is 8.23%, while Volatility Shares 2x Bitcoin Strategy ETF (BITX) has a volatility of 32.40%. This indicates that FBTCX experiences smaller price fluctuations and is considered to be less risky than BITX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.